Stockscreener 앱 받기
5.34
3.61%
-0.20
시간 외 거래:
5.33
-0.010
-0.19%
Helus Pharma Inc 주식(HELP)의 최신 뉴스
symbol__ Stock Quote Price and Forecast - CNN
Helus Pharma Partners With TARA Mind to Boost Phase 3 Depression Trial in Veterans After U.S. Executive Order - TipRanks
Helus Pharma (Nasdaq: HELP) partners with TARA Mind to boost veteran trial access - Stock Titan
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Jefferies reiterates Helus Pharma stock rating on anxiety data - Investing.com
Cybin Inc. will Change its Name to Helus Pharma - marketscreener.com
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - The Manila Times
Helus turns to TARA Mind to reach veterans for depression trial - Stock Titan
Helus Pharma CEO to Spotlight Mental Health Innovation at 29th Milken Global Conference - TipRanks
Helus Pharma (CYBN) interim CEO to join Milken Global Conference health innovation panel - Stock Titan
Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference - The Manila Times
Helus Pharma Partners With TARA Mind to Boost Phase 3 Trial Recruitment for Major Depressive Disorder in Veterans - citybuzz -
Helus Pharma Aligns With U.S. Veteran Mental Health Push in New TARA Mind Partnership - TipRanks
Cybin (CYBN) Helus Pharma joins TARA Mind to boost HLP003 Phase 3 veteran trial - Stock Titan
Helus Pharma partners with TARA Mind for trial recruitment By Investing.com - Investing.com South Africa
Helus Pharma partners with TARA Mind for trial recruitment - Investing.com
Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health - ChartMill
HELP | Cybin Inc. Common Stock Insider Trading - Quiver Quantitative
Helus Pharma propels therapeutic innovation in mental health and commences trading on Nasdaq - MSN
Helus Pharma CEO Michael Cola steps down; Eric So takes interim CEO role - MSN
Does Robert Langer’s Arrival Reframe Confidence in Cybin’s (HELP) Clinical Strategy and Execution Risk? - Yahoo Finance
Helus Pharma Inc. (HELP) News, Articles, Events & Latest Updates - Stocktwits
Chutes & Ladders—Helus shuffles out CEO after two months, adds experience to science board - Fierce Biotech
Helus Pharma adds Langer, Brannan to scientific advisory board By Investing.com - Investing.com India
Helus Pharma Adds Langer and Brannan to Advisory Board to Bolster Late-Stage Mental Health Pipeline - TipRanks
Helus Pharma (Nasdaq: HELP) adds Langer and Brannan to scientific board - Stock Titan
Helus Pharma adds Langer, Brannan to scientific advisory board - Investing.com
Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan - The Manila Times
How Leadership Turnover at Helus Pharma Will Impact Cybin’s (HELP) Execution Narrative - simplywall.st
Trump's Executive Order May Boost Psychedelic Stocks. Here Are 7 to Buy in 2026 - U.S. News Money
Helus Pharma CEO Michael Cola steps down at board’s request By Investing.com - Investing.com India
Helus Pharma Backs U.S. Executive Order Accelerating Psychedelic Treatment Pathways - TipRanks
Helus Pharma (Nasdaq: CYBN) aligns late-stage NSA pipeline with U.S. psychedelic policy push - Stock Titan
Helus Pharma (CYBN) CEO steps down as co-founder Eric So becomes interim chief - Stock Titan
Psychedelic Stocks Surge After Executive Order, Focus on Compass Pathways (CMPS) - GuruFocus
Helus Pharma Brd Starts Process to Find Permanent CEO >HELP - Moomoo
Helus Pharma CEO Michael Cola steps down at board’s request - Investing.com
Helus Pharma Says Eric So To Resume Role As Interim Chief Executive Officer - TradingView
Helus Pharma welcomes White House order on psychedelic therapies By Investing.com - Investing.com UK
1.87%
1.17%
자본화:
|
볼륨(24시간):